Atrion Corp
ATRI
Surgical & Medical Instruments & Apparatus
Mkt Cap
$802.6MPE
39.92Debt
-Cash
$7.135MEV
-FCF
$11.54MP/E Ratio
39.92Debt
-Cash
$7.135MEV
-FCF
$11.54MCharts data: {"Earnings":[{"time":"2014-12-30","value":27808000},{"time":"2015-12-30","value":28925000},{"time":"2016-12-30","value":27581000},{"time":"2017-12-30","value":36593000},{"time":"2018-12-30","value":34255000},{"time":"2019-12-30","value":36761000},{"time":"2020-12-30","value":32115000},{"time":"2021-12-30","value":33055000},{"time":"2022-12-30","value":35008000},{"time":"2023-12-30","value":19411000}],"Sales":[{"time":"2014-12-30","value":140762000},{"time":"2015-12-30","value":145733000},{"time":"2016-12-30","value":143487000},{"time":"2017-12-30","value":146595000},{"time":"2018-12-30","value":152448000},{"time":"2019-12-30","value":155066000},{"time":"2020-12-30","value":147591000},{"time":"2021-12-30","value":165009000},{"time":"2022-12-30","value":183506000},{"time":"2023-12-30","value":169326000}],"Net Margins":[{"time":"2014-12-30","value":0.19755331694633496},{"time":"2015-12-30","value":0.19847941097760974},{"time":"2016-12-30","value":0.19221950420595593},{"time":"2017-12-30","value":0.24961970053548893},{"time":"2018-12-30","value":0.2246995696893367},{"time":"2019-12-30","value":0.2370667973637032},{"time":"2020-12-30","value":0.21759456877451877},{"time":"2021-12-30","value":0.2003224066566066},{"time":"2022-12-30","value":0.19077305374211198},{"time":"2023-12-30","value":0.11463685435196012}],"Assets":[{"time":"2014-12-30","value":171514000},{"time":"2015-12-30","value":164336000},{"time":"2016-12-30","value":182593000},{"time":"2017-12-30","value":203780000},{"time":"2018-12-30","value":231216000},{"time":"2019-12-30","value":262031000},{"time":"2020-12-30","value":266890000},{"time":"2021-12-30","value":267264000},{"time":"2022-12-30","value":264712000},{"time":"2023-12-30","value":260825}],"Stockholders Equity":[{"time":"2014-12-30","value":149570000},{"time":"2015-12-30","value":144098000},{"time":"2016-12-30","value":162988000},{"time":"2017-12-30","value":184388000},{"time":"2018-12-30","value":210767000},{"time":"2019-12-30","value":237870000},{"time":"2020-12-30","value":240442000},{"time":"2021-12-30","value":244296000},{"time":"2022-12-30","value":239541000},{"time":"2023-12-30","value":242889}],"ROE":[{"time":"2014-12-30","value":0.18591963629070002},{"time":"2015-12-30","value":0.20073144665436024},{"time":"2016-12-30","value":0.16922104694824158},{"time":"2017-12-30","value":0.198456515608391},{"time":"2018-12-30","value":0.16252544278753314},{"time":"2019-12-30","value":0.15454239710766385},{"time":"2020-12-30","value":0.13356651500153882},{"time":"2021-12-30","value":0.13530716835314535},{"time":"2022-12-30","value":0.14614617121912324},{"time":"2023-12-30","value":79.91716380733587}],"ROA":[{"time":"2014-12-30","value":0.2379805730144478},{"time":"2015-12-30","value":0.25867734397819103},{"time":"2016-12-30","value":0.21427984643441972},{"time":"2017-12-30","value":0.2025419570124644},{"time":"2018-12-30","value":0.18038111549373745},{"time":"2019-12-30","value":0.15467253874541562},{"time":"2020-12-30","value":0.14413054067218703},{"time":"2021-12-30","value":0.14378666786398467},{"time":"2022-12-30","value":0.15343845386684396},{"time":"2023-12-30","value":0.08656762196875299}]}
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of specialized medical devices that include disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Sector
![GKOS Logo](data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' width='18' height='18'><defs><linearGradient id="a" x1="3.349" x2="21.904" y1="3.122" y2="24.434" gradientUnits="userSpaceOnUse"><stop stop-color="%231A1E21"/><stop offset="1" stop-color="%2306060A"/></linearGradient></defs><path fill="url(%23a)" d="M0 0h18v18H0z"/><text x='50%' y='52%' dominant-baseline='middle' text-anchor='middle' font-size='5' font-family='sans-serif' fill='gray'>GKOS</text></svg>){kind=small}
![GMED Logo](data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' width='18' height='18'><defs><linearGradient id="a" x1="3.349" x2="21.904" y1="3.122" y2="24.434" gradientUnits="userSpaceOnUse"><stop stop-color="%231A1E21"/><stop offset="1" stop-color="%2306060A"/></linearGradient></defs><path fill="url(%23a)" d="M0 0h18v18H0z"/><text x='50%' y='52%' dominant-baseline='middle' text-anchor='middle' font-size='5' font-family='sans-serif' fill='gray'>GMED</text></svg>){kind=small}
DCF
Discounted Cash Flow Valuation of Atrion Corp
Value
Growth
%
%
Discount
%
%
Multiple
| g\r | +10% | +11% | +12% | +13% | +14% |
|---|---|---|---|---|---|
| 0% | 10 | 9 | 8 | 8 | 7 |
| +1% | 11 | 10 | 9 | 8 | 8 |
| +2% | 13 | 11 | 10 | 9 | 8 |
| +3% | 14 | 13 | 11 | 10 | 9 |
| +4% | 17 | 14 | 12 | 11 | 10 |
| Years | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | TV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF | $11.54M | $10.49M | $9.532M | $8.665M | $7.876M | $7.16M | $6.508M | $5.916M | $5.378M | $4.888M | $4.444M | $44.44M |
| DCF | $9.118M | $7.207M | $5.697M | $4.503M | $3.56M | $2.814M | $2.224M | $1.758M | $1.39M | $1.098M | $10.98M | |
| Value | $50.35M | |||||||||||
In the chart Earnings are multiplied by this value.
Earnings Growth -1.7%
Earnings Stability 7.5%
Competitiveness and MOAT
High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.
| Years | 12-2015 | 12-2016 | 12-2017 | 12-2018 | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 20% | 19% | 25% | 22% | 24% | 22% | 20% | 19% | 11% | 11% |
| ROA | 26% | 21% | 20% | 18% | 15% | 14% | 14% | 15% | 8.7% | -0.48% |
| ROE | 20% | 17% | 20% | 16% | 15% | 13% | 14% | 15% | 8K% | 8.3% |
What is the average Net Margin?
The average Net Margin over the past 5 years is +19.75%.
What is the trend of Net Margin?
The trend of Net Margin over the past 5 years is -2.02%.
What is the average Return on Assets (ROA)?
The average ROA over the past 5 years is +14.38%.
What is the trend of Return on Assets (ROA)?
The trend of ROA over the past 5 years is -1.35%.
What is the average Return on Equity (ROE)?
The average ROE over the past 5 years is +1.34K%.
What is the trend of Return on Equity (ROE)?
The trend of ROE over the past 5 years is +1.14K%.
Safety & Stabiliy
Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.
| Years | 12-2015 | 12-2016 | 12-2017 | 12-2018 | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt FCF | - | - | - | - | - | - | - | - | - | - |
| Debt Equity | - | - | - | - | - | - | - | - | - | - |
| MIN | ||||||||||
| Graham Stability | - | - | 100% | 100% | 100% | 90% | 96% | 100% | 58% | 58% |
What is the Debt/FCF?
The Debt/FCF trailing twelve month is -.
What is the trend of Debt/FCF?
The trend of Debt/FCF over the past 5 years is -.
What is the Graham’s Stability?
Graham’s Stability measure stands at 0.58.
Growth
Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.
| Years | 12-2016 | 12-2018 | 12-2020 | 12-2022 | Trend |
|---|---|---|---|---|---|
| Revenue | 2.4% | 2.1% | 4.7% | -7.7% | 0.061% |
| Net Income | -4.9% | -11% | -15% | -45% | -3.8% |
| Stockholders Equity | -61% | -74% | -90% | -100% | -7.8% |
| FCF | - | - | - | - | -6.1% |
What is the 5 year Revenue CAGR?
The Revenue CAGR over the past 5 years is +2.12%.
What is the trend of Revenue growth?
The trend of Revenue growth rate over the past 5 years is +0.06%.
What is the 5 year Earnings CAGR?
The Earnings CAGR over the past 5 years is -10.74%.
What is the trend of Earnings growth?
The trend of Earnings growth rate over the past 5 years is -3.81%.
What is the 5 year Equity CAGR?
The Equity CAGR over the past 5 years is -74.16%.
What is the trend of Equity growth?
The trend of Equity growth rate over the past 5 years is -7.77%.
What is the 5 year FCF CAGR?
The FCF CAGR over the past 5 years is -.
What is the trend of FCF growth?
The trend of FCF growth rate over the past 5 years is -6.09%.